Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors and evades HLA I-driven inhibition
Stacey N. Lee, Riley J. Arseneau, Thomas Arnason, Jeanette E. Boudreau
This study identifies key NK cell ligands on pancreatic adenocarcinoma that enable effective allogeneic NK cell therapy by evading HLA I inhibition.
Journal for ImmunoTherapy of Cancer · Feb 1, 2026Peer-reviewedImmunology